Early Life and Education
Xie Liangzhi, born in China, pursued higher education in the field of chemical engineering. He earned a bachelor's degree in 1987 and a master's degree in 1990 from Dalian Institute of Technology (now Dalian University of Technology). In 1996, he obtained his Ph.D. from the Massachusetts Institute of Technology (MIT).
Rise to Success
Xie's career began with a research fellowship at Merck & Co. Inc. in the U.S. in 1996. He worked on the development of viral vaccines. In 2002, Xie returned to China and founded Sino Biological Inc., a biomedical high-tech company based in Beijing. He also founded Shenzhou Cell Biotechnology Group Co., Ltd.. His companies have undertaken several scientific and technological development projects. On June 22, 2020, shares in SinocellTech, where he is chairman, climbed significantly on their debut, boosting his fortune.
Key Business Strategies
Xie's companies focus on the development and manufacturing of biopharmaceutical drugs, including monoclonal antibodies, recombinant proteins, and vaccines. Sino Biological Inc. has established advanced technology platforms and partnerships with major pharmaceutical companies.
Philanthropy
Information on Xie Liangzhi's specific philanthropic activities and amounts could not be found via search.
